C
Cormorant Asset Management, LLC
Hedge Fund • Long/Short
Cormorant Asset Management, LLC's hedge fund institution portfolio and latest SEC filings
CEOBihua Chen
Top Holdings
Largest long holdings in Cormorant Asset Management, LLC's portfolio (67.2% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Unknown Unknown | $207.0M | 16.13% | +$207.0M New | 22.57% 17.9M shares | |
Biotechnology Healthcare | $118.5M | 9.23% | — | 12.08% 8.3M shares | |
Unknown Unknown | $94.8M | 7.39% | +$7.5M Bought | 6.92% 3.2M shares | |
Biotechnology Healthcare | $72.7M | 5.66% | -$10.4M Sold | 0.73% 1.4M shares | |
Biotechnology Healthcare | $65.0M | 5.07% | -$3.9M Sold | 3.81% 4.0M shares | |
Biotechnology Healthcare | $64.3M | 5.01% | — | 14.94% 1.1M shares | |
Biotechnology Healthcare | $63.6M | 4.96% | -$2.1M Sold | 1.40% 775.0K shares | |
Biotechnology Healthcare | $61.9M | 4.82% | -$15.8M Sold | 0.20% 430.0K shares | |
Biotechnology Healthcare | $61.9M | 4.82% | — | 1.93% 2.2M shares | |
Biotechnology Healthcare | $53.0M | 4.13% | -$33.1M Sold | 4.75% 1.0M shares |
Analytics
Portfolio insights and performance metrics for Cormorant Asset Management, LLC
GthenA